6l15
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 6l15 is ON HOLD Authors: Zhang, W., Xie, Y., Cao, R., Huang, N., Zhou, Y. Description: Crystal structure of Ser/Thr kinase Pim1 in complex with 10-...) |
|||
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives== | |
+ | <StructureSection load='6l15' size='340' side='right'caption='[[6l15]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6L15 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6L15 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=E2O:7-chloranyl-5-[3-[(3~{S})-piperidin-3-yl]propyl]pyrido[3,4-b][1,4]benzoxazine'>E2O</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6l15 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6l15 OCA], [https://pdbe.org/6l15 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6l15 RCSB], [https://www.ebi.ac.uk/pdbsum/6l15 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6l15 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Pim-1 kinase has been widely regarded as an attractive target for anticancer drugs. Here, we reported our continued efforts in structure-based optimization of compound 10-DEBC, a previously identified micromolar Pim-1 inhibitor. Guided by the Site Identification by Ligand Competitive Saturation (SILCS) method, we quickly obtained a series of 10-DEBC derivatives with significantly improved activity and selectivity. In particular, compound 26 exhibited an IC50 value of 0.9 nM, as well as 220- and 8-fold selectivity over Pim-2 and Pim-3 kinases, respectively. | ||
- | + | Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors.,Li G, Zhang W, Xie Y, Li Y, Cao R, Zheng G, Huang N, Zhou Y J Chem Inf Model. 2020 May 14. doi: 10.1021/acs.jcim.0c00245. PMID:32407627<ref>PMID:32407627</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: Cao | + | <div class="pdbe-citations 6l15" style="background-color:#fffaf0;"></div> |
- | [[Category: Huang | + | |
- | [[Category: | + | ==See Also== |
- | [[Category: | + | *[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]] |
- | [[Category: Zhou | + | == References == |
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Cao R]] | ||
+ | [[Category: Huang N]] | ||
+ | [[Category: Xie Y]] | ||
+ | [[Category: Zhang W]] | ||
+ | [[Category: Zhou Y]] |
Current revision
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives
|
Categories: Large Structures | Cao R | Huang N | Xie Y | Zhang W | Zhou Y